Exactech Inc. (EXAC)

49.25
0.00 (0.00)
Prev Close 49.25
Open 49.25
Day Low/High 49.25 / 49.30
52 Wk Low/High 23.75 / 50.95
Volume 256.05K
Avg Volume 176.80K
Exchange
Shares Outstanding 14.42M
Market Cap 711.10M
Div & Yield N.A. (N.A)

Latest News

Notable Monday Option Activity: EXAC, GIFI, MMM

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Exactech, Inc. , where a total of 515 contracts have traded so far, representing approximately 51,500 underlying shares.

EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC Is Seeking More Cash For Shareholders Of Exactech, Inc.

EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC Is Seeking More Cash For Shareholders Of Exactech, Inc.

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors...

EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash For Shareholders Of Exactech, Inc.

EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash For Shareholders Of Exactech, Inc.

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors...

Exactech Announces Successful First Surgery With Vantage ® Total Ankle Mobile Bearing System

Exactech Announces Successful First Surgery With Vantage ® Total Ankle Mobile Bearing System

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new Vantage® Total Ankle Mobile...

Exactech And TPG Capital Announce Amended Merger Agreement Providing For Increase In Merger Consideration To $49.25 Per Share

Exactech And TPG Capital Announce Amended Merger Agreement Providing For Increase In Merger Consideration To $49.25 Per Share

Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has entered into an amendment to its...

The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Of Exactech, Inc. In Connection With The Sale Of The Company To TPC Capital

The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Of Exactech, Inc. In Connection With The Sale Of The Company To TPC Capital

The Law Offices of Vincent Wong are investigating the Board of Directors of Exactech, Inc.

Exactech Announces Successful First Revision Knee Replacement Surgery With Truliant® Instrumentation

Exactech Announces Successful First Revision Knee Replacement Surgery With Truliant® Instrumentation

Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first revision knee surgery was performed using...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Exactech, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Exactech, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Exactech Q3 Revenue $61.4 Million

Exactech Q3 Revenue $61.4 Million

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the third quarter of 2017 increased 2% to...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Exactech, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Exactech, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Of Exactech, Inc. In Connection With The Sale Of The Company To TPC Capital

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Of Exactech, Inc. In Connection With The Sale Of The Company To TPC Capital

The Law Offices of Vincent Wong are investigating the Board of Directors of Exactech, Inc.

Exactech Cancels Q3 Earnings Call Previously Scheduled For Tuesday, October 31, 2017

Exactech Cancels Q3 Earnings Call Previously Scheduled For Tuesday, October 31, 2017

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that, due to its definitive agreement with TPG...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Concerning Whether The Sale Of Exactech, Inc. To TPC Capital Is Fair To Shareholders

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Concerning Whether The Sale Of Exactech, Inc. To TPC Capital Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc.

Exactech, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Acquisition By TPG Capital

Exactech, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Acquisition By TPG Capital

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Exactech, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of Exactech, Inc. To TPC Capital Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of Exactech, Inc. To TPC Capital Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc.

Exactech Enters Definitive Agreement With TPG Capital To Go Private

Exactech Enters Definitive Agreement With TPG Capital To Go Private

Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that it has entered into a definitive merger agreement...

Exactech Comments On Impact Of Hurricanes Irma And Harvey; Adjusts Q3 Earnings Guidance And Announces Q3 Earnings Call

Exactech Comments On Impact Of Hurricanes Irma And Harvey; Adjusts Q3 Earnings Guidance And Announces Q3 Earnings Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it is adjusting guidance for the third quarter of 2017...

Exactech To Present To Investors At Baird 2017 Global Healthcare Conference

Exactech To Present To Investors At Baird 2017 Global Healthcare Conference

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will present to investors at the Baird 2017 Global Healthcare...